MindMed Joins Russell 2000® Index

Clinical stage biopharmaceutical company, MindMed (Nasdaq: MNMD) has been accepted to the Russell 2000® Index and the broad-market Russell 3000® Index. Membership in the Russell 3000® Index means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as in the appropriate growth and value style indexes. The company’s shares… [Read More]

Biotech Making Moves: Lexaria (LEXX) Completes Dosing in Second GLP-1 Human Pilot Study

Today biotech company and global innovator in drug delivery platforms Lexaria Bioscience Corp. (LEXX), announced its human pilot study #2, GLP-1-H24-2 has now completed all dosing. This Study was a three-arm, crossover investigation comparing three 7 mg semaglutide dose formulations which were a positive control Rybelsus® swallowed tablet, DehydraTECH-semaglutide swallowed capsules, and for the first… [Read More]

It’s Never Too Late in Life to Toke: Tilray (TLRY) Releases “Medical Cannabis in Older Patients Study” Findings

Tilray Medical, a division of Tilray Brands, Inc. (TLRY) and a global leader in medical cannabis, announced a new scientific publication titled, “Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes.” This study, known as the Medical Cannabis in Older Patients Study (MCOPS), is a multi-site,… [Read More]

CytoSorbents Receives Regulatory Approval of CytoSorb® in Taiwan ; Secures $20M Credit Facility

CytoSorbents Corporation (Nasdaq: CTSO) has secured regulatory approval from the Taiwan Food and Drug Administration (TFDA) for CytoSorb®, the company’s extracorporeal cytokine adsorber that reduces “cytokine storm” or “cytokine release syndrome” in common critical illnesses. CytoSorb is approved in the European Union and distributed in 75 countries worldwide. CytoSorbents’ share price rose 5.69% in trading… [Read More]

Stocks making the biggest moves premarket: Chemours, Intel, BP and more

Early Morning Market Movers You Need to Know Chemours – With an impressive 3% addition to its stock value, this chemical behemoth is turning heads after an upgrade from ‘buy’ to ‘neutral’ by UBS. The positive forecast is credited to a growing demand and advantageous pricing for refrigerants set to take off next year. Nvidia… [Read More]

Soligenix Announces Promising Interim Results for Extended HyBryte™ Treatment in Cutaneous T-Cell Lymphoma Study; Shares Surge over 200% Premarket

Results Show Sustained Efficacy and Safety in Extended Treatment of CTCL Soligenix, Inc. (Nasdaq: SNGX), a late stage biopharmaceutical company, has released an interim update on an ongoing study for HyBryte™ in treating early-stage cutaneous T-cell lymphoma (CTCL). The study, led by Dr. Ellen Kim of the Hospital of the University of Pennsylvania, is supported… [Read More]

Should You Consider Putting Your Money on Super Micro Computer, Inc. (SMCI), the Most-Viewed Stock?

Lately, Super Micro Computer (SMCI) has been garnering significant attention as one of the most-viewed stocks , prompting us to assess various factors that could impact its immediate stock performance. In the past month, this server technology firm’s shares have delivered a return of +10.1%, outpacing the Zacks S&P 500 composite’s +4.1% change. During that… [Read More]

Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more

Here are today’s midday highlights from the trading floor. Paramount Global’s shares dipped 2% upon the announcement of its merger with Skydance Media. The deal, accompanied by an $8 billion investment from Skydance and its financial backers, also includes the acquisition of National Amusements, Paramount’s controlling shareholder. Morphic Holding was in the spotlight with its… [Read More]

Creative Realities (CREX) Announces Membership of the Russell Microcap® Index

The leading provider of digital signage and media solutions company, Creative Realities (CREX) announced it has become a member of the Russell Microcap® Index.  Russell indices are widely used by investors and managers as benchmarks related to investment strategies. As of December 31,2023, Russell’s US indexes serve as the benchmark for about $10.5 trillion in… [Read More]